Found: 4
Select item for more details and to access through your institution.
Case Report: Marked Survival Advantage of Two Colorectal Cancer Patients with Liver Metastases Treated with Vigil and FOLFOX-6.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Long-Term Follow-Up of Gemogenovatucel-T (Vigil) Survival and Molecular Signals of Immune Response in Recurrent Ovarian Cancer.
- Published in:
- Vaccines, 2021, v. 9, n. 8, p. 894, doi. 10.3390/vaccines9080894
- By:
- Publication type:
- Article
Pilot Study of Combination Gemogenovatucel-T (Vigil) and Durvalumab in Women With Relapsed BRCA-wt Triple-Negative Breast or Ovarian Cancer.
- Published in:
- Clinical Medicine Insights: Oncology, 2022, p. 1, doi. 10.1177/11795549221110501
- By:
- Publication type:
- Article
KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex.
- Published in:
- PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0193644
- By:
- Publication type:
- Article